(19)
(11) EP 1 848 454 A1

(12)

(43) Date of publication:
31.10.2007 Bulletin 2007/44

(21) Application number: 06720825.6

(22) Date of filing: 14.02.2006
(51) International Patent Classification (IPC): 
A61K 38/20(2006.01)
A61K 31/675(2006.01)
A61K 31/475(2006.01)
A61P 35/00(2006.01)
A61K 39/395(2006.01)
A61K 31/704(2006.01)
A61K 31/573(2006.01)
(86) International application number:
PCT/US2006/005536
(87) International publication number:
WO 2006/089064 (24.08.2006 Gazette 2006/34)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 15.02.2005 US 653233 P
14.04.2005 US 671376 P

(71) Applicant: Novartis Vaccines and Diagnostics, Inc.
Emeryville, CA 94662-8097 (US)

(72) Inventors:
  • DENIS-MIZE, Kimberly, c/o Chiron Corporation
    Emeryville, CA 94608 (US)
  • HEISE, Carla, c/o Chiron Corporation
    Emeryville, CA 94608 (US)
  • MENEZES, Daniel, c/o Chiron Corporation
    Emeryville, CA 94608 (US)
  • WILSON, Susan E., c/o Chiron Corporation
    Emeryville, CA 94608 (US)

(74) Representative: Marshall, Cameron John et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA
London WC1A 2RA (GB)

   


(54) METHODS FOR TREATING LYMPHOMAS USING A COMBINATION OF A CHEMOTHERAPEUTIC AGENT AND IL-2 AND OPTIONALLY AN ANTI-CD20 ANTIBODY